The Circadian Clock in Cancer Development and Therapy - Progress in Molecular Biology and Translational Science - page 277

367. Yamamoto T, Shimano H, Nakagawa Y, et al. SREBP-1 interacts with hepatocyte
nuclear factor-4 alpha and interferes with PGC-1 recruitment to suppress hepatic
gluconeogenic genes. J Biol Chem . 2004;279(13):12027-12035.
368. So AY, Bernal TU, Pillsbury ML, Yamamoto KR, Feldman BJ. Glucocorticoid reg-
ulation of the circadian clock modulates glucose homeostasis. Proc Natl Acad Sci USA .
2009;106(41):17582-17587.
369. Pezuk P, Mohawk JA, Wang LA, Menaker M. Glucocorticoids as entraining signals for
peripheral circadian oscillators. Endocrinology . Oct 2012;153(10):4775-4783.
370. Furness JB. The organisation of the autonomic nervous system: peripheral connections.
Auton Neurosci . 2006;130(1-2):1-5.
371. Shibata S. Neural regulation of the hepatic circadian rhythm. Anat Rec ADiscov Mol Cell
Evol Biol . 2004;280(1):901-909.
372. Vujovic N, Davidson AJ, Menaker M. Sympathetic input modulates, but does not
determine, phase of peripheral circadian oscillators. Am J Physiol Regul Integr Comp Phy-
siol . 2008;295(1):R355-R360.
373. Takekida S, Yan L, Maywood ES, Hastings MH, Okamura H. Differential adrenergic
regulation of the circadian expression of the clock genes Period1 and Period2 in the rat
pineal gland. Eur J Neurosci . 2000;12(12):4557-4561.
374. Logan RW, Arjona A, Sarkar DK. Role of sympathetic nervous system in the entrain-
ment of circadian natural-killer cell function. Brain Behav Immun . 2011;25(1):101-109.
375. Mendez-Ferrer S, Lucas D, Battista M, Frenette PS. Haematopoietic stem cell release is
regulated by circadian oscillations. Nature . 2008;452(7186):442-447.
376. Kang J, Shi Y, Xiang B, et al. A nuclear function of beta-arrestin1 in GPCR signaling:
regulation of histone acetylation and gene transcription. Cell . 2005;123(5):833-847.
377. Tilley DG. G protein-dependent and G protein-independent signaling pathways and
their impact on cardiac function. Circ Res . 2011;109(2):217-230.
378. Reiter E, Ahn S, Shukla AK, Lefkowitz RJ. Molecular mechanism of beta-arrestin-
biased agonism at seven-transmembrane receptors. Annu Rev Pharmacol Toxicol .

2012;52:179-197.
379. DeFea KA. Beta-arrestins as regulators of signal termination and transduction: how do
they determine what to scaffold? Cell Signal . 2011;23(4):621-629.
380. Verkaar F, van Rosmalen JW, Blomenrohr M, et al. G protein-independent cell-based
assays for drug discovery on seven-transmembrane receptors. Biotechnol Annu Rev .
2008;14:253-274.
381. Ling J, Kumar R. Crosstalk between NFkB and glucocorticoid signaling: a potential
target of breast cancer therapy. Cancer Lett . 2012;322(2):119-126.
382. Grossmann C, Gekle M. Interaction between mineralocorticoid receptor and epider-
mal growth factor receptor signaling. Mol Cell Endocrinol . 2012;350(2):235-241.
383. Schakman O, Gilson H, Kalista S, Thissen JP. Mechanisms of muscle atrophy induced
by glucocorticoids. Horm Res . 2009;72(Suppl 1):36-41.
384. Mulholland DJ, Dedhar S, Coetzee GA, Nelson CC. Interaction of nuclear receptors
with the Wnt/beta-catenin/Tcf signaling axis: Wnt you like to know? Endocr Rev .
2005;26(7):898-915.
385. Lang F, Perrotti N, Stournaras C. Colorectal carcinoma cells—regulation of survival
and growth by SGK1. Int J Biochem Cell Biol . 2010;42(10):1571-1575.
386. Zhang JY, Selim MA. The role of the c-Jun N-terminal Kinase signaling pathway in
skin cancer. Am j cancer res . 2012;2(6):691-698.
387. Romitti M, Ceolin L, Siqueira DR, Ferreira CV, Wajner SM, Maia AL. Signaling
pathways in follicular cell-derived thyroid carcinomas (review). Int J Oncol . Jan

2013;42(1):19-28.
388. Servillo G, Della Fazia MA, Sassone-Corsi P. Coupling cAMP signaling to transcription
in the liver: pivotal role of CREB and CREM. Exp Cell Res . 2002;275(2):143-154.